Inventor · disambiguated record
Thomas Shenk
Also filed as: SHENK THOMAS · SHENK THOMAS E
28 granted patents·21 pending applications·1,406 citations·filing 1986–2021
97Inventor score
Top patents by PatentIndex Score
49 records- 0198US6951753B2Helper-free stocks of recombinant adeno-associated virus vectorsUNIV PRINCETON·Filed 2002·Granted Oct 4, 2005·142 cites·3 claims
- 0297US5436146AHelper-free stocks of recombinant adeno-associated virus vectorsUNIV PRINCETON·Filed 1993·Granted Jul 25, 1995·590 cites·47 claims
- 0396US5753500AHelper-free stocks of recombinant adeno-associated virus vectorsUNIV PRINCETON·Filed 1995·Granted May 19, 1998·212 cites·13 claims
- 0495US8173362B2Cytomegalovirus surface protein complex for use in vaccines and as a drug targetSHENK THOMAS·Filed 2010·Granted May 8, 2012·30 cites·12 claims
- 0594US7704510B2Cytomegalovirus surface protein complex for use in vaccines and as a drug targetUNIV PRINCETON·Filed 2007·Granted Apr 27, 2010·26 cites·12 claims
- 0692US5382510AMethods of diagnosing pre-cancer or cancer states using probes for detecting mutant p53UNIV PRINCETON·Filed 1992·Granted Jan 17, 1995·133 cites·6 claims
- 0790US8158677B2Treatment of viral infections by modulation of host cell metabolic pathwaysMUNGER JOSH·Filed 2008·Granted Apr 17, 2012·21 cites·11 claims
- 0889US9168269B2Inhibitors of long and very long chain fatty acid metabolism as broad spectrum anti-viralsKOYUNCU EMRE·Filed 2011·Granted Oct 27, 2015·13 cites·4 claims
- 0986US9029413B2Treatment of viral infections by modulation of host cell metabolic pathwaysMUNGER JOSH·Filed 2012·Granted May 12, 2015·11 cites·31 claims
- 1086US6936416B2Expression monitoring for human cytomegalovirus (HCMV) infectionAFFYMETRIX INC·Filed 2001·Granted Aug 30, 2005·14 cites·8 claims
- 1184US8828399B2Cytomegalovirus surface protein complex for use in vaccines and as a drug targetSHENK THOMAS·Filed 2012·Granted Sep 9, 2014·3 cites·28 claims
- 1284US4882269AAmplified hybridization assayUNIV PRINCETON·Filed 1986·Granted Nov 21, 1989·100 cites·62 claims
- 1378US9149445B2Inhibition of glycerol-3-phosphate acyltransferase (GPAT) and associated enzymes for treatment of viral infectionsLIU SEAN·Filed 2010·Granted Oct 6, 2015·2 cites·6 claims
- 1476US10174290B2Method to increase the infectivity of virus particlesSHENK THOMAS·Filed 2012·Granted Jan 8, 2019·2 cites·5 claims
- 1575US5424188AAmplified hybridization assayUNIV PRINCETON·Filed 1992·Granted Jun 13, 1995·53 cites·19 claims
- 1672US11129891B2Cytomegalovirus surface protein complex for use in vaccines and as a drug targetUNIV PRINCETON·Filed 2019·Granted Sep 28, 2021·0 cites·3 claims
- 1772US9439960B2Cytomegalovirus vaccines and methods of productionSHENK THOMAS·Filed 2008·Granted Sep 13, 2016·1 cites·3 claims
- 1871US2021380952A1Method to Produce Virus in Cultured Cells Supplemented With Alpha-KetoglutarateUNIV PRINCETON·Filed 2021·Application pending·0 cites
- 1970US6489162B1Helper-free stocks of recombinant adeno-associated virus vectorsUNIV PRINCETON·Filed 1998·Granted Dec 3, 2002·17 cites·13 claims
- 2067US2019218524A1Method to Produce Virus in Cultured Cells Supplemented With Alpha-KetoglutarateUNIV PRINCETON·Filed 2019·Application pending·0 cites
- 2164US2018298348A1Method to Produce Virus in Cultured Cells Supplemented With Alpha-KetoglutarateUNIV PRINCETON·Filed 2018·Application pending·0 cites
- 2263US11726088B2Sirtuin 4 (SIRT4) lipoamidase activity and uses thereofUNIV PRINCETON·Filed 2020·Granted Aug 15, 2023·0 cites·12 claims
- 2363US2014370026A1Cytomegalovirus Surface Protein Complex For Use in Vaccines and as a Drug TargetUNIV PRINCETON·Filed 2014·Application pending·0 cites
- 2460US10300130B2Cytomegalovirus vaccines and methods of productionUNIV PRINCETON·Filed 2016·Granted May 28, 2019·0 cites·7 claims
- 2560US2015240215A1Method to produce virus in cultured cells supplemented with alpha-ketoglutarateUNIV PRINCETON·Filed 2013·Application pending·0 cites
- 2659US11008551B2Method to increase the infectivity of virus particlesUNIV PRINCETON·Filed 2018·Granted May 18, 2021·0 cites·2 claims
- 2759US10813934B2Sirtuin modulators as inhibitors of cytomegalovirusUNIV PRINCETON·Filed 2016·Granted Oct 27, 2020·0 cites·8 claims
- 2859US2005287662A1Helper-free stocks of recombinant adeno-associated virus vectorsSHENK THOMAS E·Filed 2005·Application pending·0 cites
- 2958US5674730AEukaryotic cells comprising a DNA sequence encoding a bacterial-viral chimeric transactivator proteinUNIV PRINCETON·Filed 1993·Granted Oct 7, 1997·20 cites·11 claims
- 3058US2006003321A1Expression monitoring for human cytomegalovirus (HCMV) infectionUNIV PRINCETON·Filed 2005·Application pending·0 cites
- 3157US9212349B2Method to produce virus in cultured cellsSHENK THOMAS·Filed 2012·Granted Dec 15, 2015·0 cites·10 claims
- 3257US2009156535A1MicroRNAs for Modulating Herpes Virus Gene ExpressionUNIV PRINCETON·Filed 2008·Application pending·0 cites
- 3355US9757407B2Treatment of viral infections by modulation of host cell metabolic pathwaysUNIV PRINCETON·Filed 2015·Granted Sep 12, 2017·0 cites·1 claims
- 3452US2016271137A1Inhibitors of long and very long chain fatty acid metabolism as broad spectrum anti-viralsUNIV PRINCETON·Filed 2015·Application pending·0 cites
- 3552US2013338178A1Sirtuin modulators as inhibitors of cytomegalovirusSHENK THOMAS·Filed 2012·Application pending·0 cites
- 3650US10788492B2SIRT4 lipoamidase activity and uses thereofUNIV PRINCETON·Filed 2015·Granted Sep 29, 2020·0 cites·12 claims
- 3749US2015139949A1Anti-viral combination therapyKOYUNCU EMRE·Filed 2014·Application pending·0 cites
- 3849US2016130565A1Method to Produce Virus in Cultured CellsUNIV PRINCETON·Filed 2015·Application pending·0 cites
- 3948US2004241163A1Compositions and methods for treating inflammation and related conditionsFiled 2002·Application pending·0 cites
- 4047US5770720AUbiquitin conjugating enzymes having transcriptional repressor activityBARNES JEWISH HOSPITAL·Filed 1996·Granted Jun 23, 1998·5 cites·70 claims
- 4146US2014206678A1Inhibitors of mtor kinase as anti -viral agentSHENK THOMAS·Filed 2012·Application pending·0 cites
- 4245US2018185374A1Inhibitors of mtor kinase as anti-viral agentsMOORMAN NATHANIEL·Filed 2017·Application pending·0 cites
- 4344US5620848AMethods for detecting mutant p53UNIV PRINCETON·Filed 1994·Granted Apr 15, 1997·11 cites·2 claims
- 4444US2002055173A1Method for preparing adenovirus vectors, vectors so prepared, and uses thereofFiled 2001·Application pending·0 cites
- 4542US2022204971A1Compositions and Methods for Inhibiting Cancers and VirusesICAHN SCHOOL MED MOUNT SINAI·Filed 2019·Application pending·0 cites
- 4638US2010151441A1Human Cytomegalovirus Latency Promoting Genes, Related Virus Variants and Methods of UseUNIV PRINCETON·Filed 2006·Application pending·0 cites
- 4738US2004248135A1Methods for detemining multiple effects of drugs that modulate function of transcription regulatory proteinsFiled 2002·Application pending·0 cites
- 4838US2015335657A1Methods for Modulating Sirtuin EnzymesUNIV PRINCETON·Filed 2015·Application pending·0 cites
- 4932US2014018354A9Inhibitors of mtor kinase as anti-viral agentsMOORMAN NATHANIEL·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Thomas Shenk files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →